RE: One year since the Eisai Inc. contract RNS 02/01/2024 >>2 Jan 2025 11:19
I see three potential outcomes of this and AZ contracts
1, Failure - end of Angle?
2, Inconclusive - more prolonged tests and cash burn, or the end?
3, Success - More Contracts, Buy out or?
The device and processes do appear to be valuable. My only concern is will Parstorix reduce revenues of Big companies who just pump patients full of drugs irrespective of the outcome or will targeted drug use at least be equal or better in revenue terms, due to premiums being paid. Only time will tell although my punt is for Option 3